Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery
NCT06898814Phase 4Recruiting
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferric derisomaltose in anemia (2 arms). Primary endpoint: New Mobility Score at 12 weeks. Started Jun 2025; status: recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT06898814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06898814.